(6~S)-8-(3-pyrimidin-4-yl-1~H-pyrrolo[2,3-b]pyridin-4-yl)-1,8-diazaspiro[5.5]undecane
≥98%
- Product Code: 237451
CAS:
2226507-04-4
| Molecular Weight: | 348.44 g./mol | Molecular Formula: | C₂₀H₂₄N₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), this compound shows promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its spirocyclic structure enhances selectivity and metabolic stability, making it a valuable scaffold in the development of oral JAK inhibitors. It has also been investigated for potential use in oncology due to the role of JAK-STAT signaling in certain cancers. Preclinical studies highlight its favorable pharmacokinetic profile and reduced off-target effects compared to earlier kinase inhibitors.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | €382.96 |
+
-
|
| 25mg | 10-20 days | €1,302.21 |
+
-
|
(6~S)-8-(3-pyrimidin-4-yl-1~H-pyrrolo[2,3-b]pyridin-4-yl)-1,8-diazaspiro[5.5]undecane
Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), this compound shows promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its spirocyclic structure enhances selectivity and metabolic stability, making it a valuable scaffold in the development of oral JAK inhibitors. It has also been investigated for potential use in oncology due to the role of JAK-STAT signaling in certain cancers. Preclinical studies highlight its favorable pharmacokinetic profile and reduced off-target effects compared to earlier kinase inhibitors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :